Catalyst Wire Dossier Catalyst Wire Dossier

CVT-427 (Zolmitriptan Inhalation Powder)

zolmitriptan inhalation powder · Acorda Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CVT-427 (Zolmitriptan Inhalation Powder), covering 2016-06-06 to 2016-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults [Phase 1]

See pricing